Company Overview of Coulter Pharmaceutical, Inc.
As of December 22, 2000, Coulter Pharmaceutical, Inc. was acquired by Corixa Corporation. Coulter Pharmaceutical, Inc. develops and markets drugs and therapies for the treatment of people with cancer and autoimmune diseases. The company offers monoclonal antibody-based anti-cancer drugs that hone in on tumor cells without devastating surrounding healthy tissues. The company was incorporated in 1995 and is based in South San Francisco, California.
600 Gateway Boulevard
South San Francisco, CA 94080
Founded in 1995
Key Executives for Coulter Pharmaceutical, Inc.
Coulter Pharmaceutical, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Coulter Pharmaceutical, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.